Lower thrombolytic use for African Americans with myocardial infarction: An influence of clinical presentation?

被引:27
|
作者
Borzak, S
Joseph, C
Havstad, S
Tilley, B
Smith, ST
Housholder, SD
Gheorghiade, M
机构
[1] Henry Ford Hosp, Div Cardiovasc Med, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Inst Heart & Vasc, Detroit, MI USA
[4] Northwestern Univ, Sch Med, Div Cardiovasc, Chicago, IL USA
关键词
D O I
10.1053/hj.1999.v137.92523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background After myocardial infarction, African Americans hove been reported to undergo fewer catheterization and revascularization procedures than whites, but few studies have addressed racial variations in the delivery of thrombolytic therapy. Methods we conducted a retrospective analysis of data prospectively collected on consecutive patients admitted with acute myocardial infarction to the 16-bed coronary care unit of a large, urban reaching hospital. Results Over a 5-year period, 1948 consecutive patients were admitted with acute myocardial infarction to a single coronary care unit. Thrombolysis was administered to 19% of 1024 African Americans and 29% of 924 whites (P < .01). The initial diagnostic impression on admission was "definite" infarction less often in African Americans (30%) than in whites (43%, P < .001), a difference that appeared to largely account for the difference in thrombolytic administration in a multivariable model. Mortality adjusted for age and concomitant illnesses was similar in African Americans compared with whites (relative risk 1.0, 95% confidence interval 0.78 to 1.51). Conclusions Much of the racial variation in thrombolytic administration could be accounted for by differences in clinical presentation, an issue that requires further study.
引用
收藏
页码:338 / 345
页数:8
相关论文
共 50 条
  • [1] Lower rates of reperfusion therapy in African Americans with myocardial infarction are due to presentation and evaluation characteristics
    Manhapra, A
    Canto, JG
    Barron, HV
    Taylor, HA
    Every, NR
    Malmgren, JA
    Weaver, WD
    Rogers, WJ
    Borzak, S
    [J]. CIRCULATION, 1999, 100 (18) : 532 - 532
  • [2] Lower rates of reperfusion therapy in African Americans with myocardial infarction are due to presentation and evaluation characteristics
    Manhapra, A
    Canto, JG
    Darron, HV
    Malmgron, JA
    Taylor, HA
    Weaver, WD
    Rogers, WJ
    Borrak, S
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 260A - 260A
  • [3] Differences in the Clinical Features and Outcomes in African Americans and Whites with Myocardial Infarction
    Mehta, Rajendra H.
    Marks, David
    Califf, Robert M.
    Sohn, SeeHyang
    Pieper, Karen S.
    Van de Werf, Frans
    Peterson, Eric D.
    Ohman, E. Magnus
    White, Harvey D.
    Topol, Eric J.
    Granger, Christopher B.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (01): : 70.e1 - 70.e8
  • [4] Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
    Mak, KH
    Moliterno, DJ
    Granger, CB
    Miller, DP
    White, HD
    Wilcox, RG
    Califf, RM
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) : 171 - 179
  • [5] Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease
    Charytan, D. M.
    Setoguchi, S.
    Solomon, D. H.
    Avorn, J.
    Winkelmayer, W. C.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (09) : 938 - 945
  • [6] Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics
    Manhapra, A
    Canto, JG
    Barron, HV
    Malmgren, JA
    Taylor, H
    Rogers, WJ
    Weaver, WD
    Every, NR
    Borzak, S
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (04) : 604 - 610
  • [7] CLINICAL TRIALS OF THROMBOLYTIC AGENTS IN MYOCARDIAL-INFARCTION
    SIMON, TL
    WARE, JH
    STENGLE, JM
    [J]. ANNALS OF INTERNAL MEDICINE, 1973, 79 (05) : 712 - 719
  • [8] NEW THROMBOLYTIC AGENTS FOR USE IN MYOCARDIAL-INFARCTION
    CHARBONNIER, B
    LANG, M
    BROCHIER, M
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1987, 80 (12): : 1785 - 1791
  • [9] On the low frequency of use of thrombolytic agents in myocardial infarction
    Segura, A
    Fernandez, E
    [J]. MEDICINA CLINICA, 1998, 111 (10): : 398 - 398
  • [10] Presentation, delay, and contraindication to thrombolytic treatment in females and males with myocardial infarction
    Grace, SL
    Abbey, SE
    Bisaillon, S
    Shnek, ZM
    Irvine, J
    Stewart, DE
    [J]. WOMENS HEALTH ISSUES, 2003, 13 (06) : 214 - 221